BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 28562168)

  • 1. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q; Li H; Xie X; Qu F; Li X; Chen J
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of tacrolimus-based treatment for nephrotic idiopathic membranous nephropathy in young adults: A retrospective study.
    Zhang XJ; Ji CF; Yuan JZ; Wang L; Zhang J; Fang W; Bai DF; Hu Z
    Kaohsiung J Med Sci; 2019 Oct; 35(10):633-639. PubMed ID: 31225949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.
    Chen M; Li H; Li XY; Lu FM; Ni ZH; Xu FF; Li XW; Chen JH; Wang HY;
    Am J Med Sci; 2010 Mar; 339(3):233-8. PubMed ID: 20220333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome.
    Yuan H; Liu N; Sun GD; Jia Y; Luo P; Miao LN
    Pharmacology; 2013; 91(5-6):259-66. PubMed ID: 23652322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
    Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J
    J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy.
    Zou H; Jiang F; Xu G
    Ren Fail; 2019 Nov; 41(1):673-681. PubMed ID: 31354007
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis.
    Gong L; Xu M; Xu W; Tang W; Lu J; Jiang W; Xie F; Ding L; Qian X
    Medicine (Baltimore); 2021 Jul; 100(28):e26628. PubMed ID: 34260552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids.
    He L; Peng Y; Liu H; Liu Y; Yuan S; Liu F; Yang D; Liu H; Chen X; Shao J; Fu M
    J Nephrol; 2013; 26(3):564-71. PubMed ID: 22956434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tacrolimus combined with corticosteroids in patients with idiopathic membranous nephropathy: a systematic review and meta-analysis of randomized controlled trials.
    Tian Z; Li Y; Xie Y; Yang Y; Xu J
    Int Urol Nephrol; 2022 Oct; 54(10):2555-2566. PubMed ID: 35277831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of tacrolimus monotherapy and cyclophosphamide combined with glucocorticoid in the treatment of adult primary membranous nephropathy: protocol of a multicenter, randomized, controlled, open study.
    Chen S; Ren S; Wang AY; Tran H; Li Z; Cheng X; Liu M; Li G; Wang L; Hong D
    Trials; 2020 Feb; 21(1):219. PubMed ID: 32093742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy.
    Shang SL; Cai GY; Duan SW; Li P; Li QG; Chen XM
    BMC Nephrol; 2018 Jul; 19(1):182. PubMed ID: 30021637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of cyclophosphamide versus tacrolimus in terms of treatment effect for idiopathic membranous nephropathy: A meta-analysis.
    Li YC; Huang J; Li X; Zhao SM
    Nefrologia (Engl Ed); 2019; 39(3):269-276. PubMed ID: 30755327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis.
    Lin W; Li HY; Lin S; Zhou T
    Drug Des Devel Ther; 2019; 13():2179-2186. PubMed ID: 31308629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
    Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
    J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy.
    Peng L; Wei SY; Li LT; He YX; Li B
    J Formos Med Assoc; 2016 Jan; 115(1):11-8. PubMed ID: 26315481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
    Matsumoto Y; Shimada Y; Nojima Y; Moriki T
    Ren Fail; 2013 Aug; 35(7):936-41. PubMed ID: 23815417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial.
    Chen Y; Deng Y; Ni Z; Chen N; Chen X; Shi W; Zhan Y; Yuan F; Deng W; Zhong Y
    Am J Kidney Dis; 2013 Dec; 62(6):1068-76. PubMed ID: 23810688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy.
    Cui W; Lu X; Min X; Liu M; Guan S; Wang Y; Luo M; Li W; Li Q; Dong W; Miao L; Luo P
    Braz J Med Biol Res; 2017 Mar; 50(4):e5976. PubMed ID: 28355356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.